Maravai LifeSciences Holdings, Inc. (MRVI)
NASDAQ: MRVI · Real-Time Price · USD
2.860
-0.230 (-7.44%)
At close: Mar 27, 2026, 4:00 PM EDT
2.838
-0.022 (-0.78%)
After-hours: Mar 27, 2026, 7:15 PM EDT
MRVI Market Cap
MRVI has a market cap or net worth of $735.21 million as of March 27, 2026. Its market cap has increased by 114.18% in one year.
Market Cap
735.21M
Enterprise Value
883.03M
1-Year Change
114.18%
Ranking
Category
Stock Price
$2.86
Market Cap Chart
Since the IPO on November 20, 2020, MRVI's market cap has decreased from $2.43B to $735.21M, a decrease of -69.73%. That is a compound annual growth rate of -20.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 418.66M | -11.17% |
| Dec 31, 2025 | 471.32M | -39.03% |
| Dec 31, 2024 | 773.05M | -10.72% |
| Dec 29, 2023 | 865.84M | -54.00% |
| Dec 30, 2022 | 1.88B | -65.83% |
| Dec 31, 2021 | 5.51B | 100.45% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 20, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nautilus Biotechnology | 477.43M |
| Entrada Therapeutics | 471.28M |
| Lyell Immunopharma | 471.27M |
| enGene Holdings | 466.25M |
| Verastem | 464.65M |
| Fulcrum Therapeutics | 462.21M |
| Immix Biopharma | 461.85M |
| Assembly Biosciences | 457.96M |